UNH true valuation?

The valuation of UnitedHealth Group (UNH) appears to be relatively high compared to its peers, based on several key metrics: 1. **P/E Ratio**: UNH's P/E ratio stands at 11.12, which is above the industry average. This suggests that the stock may be overvalued by the market, as investors are willing to pay a premium for each dollar of earnings. |code|Ticker|Name|Date|P/E(TTM)|P/S|Price to Book Ratio|market_code| |---|---|---|---|---|---|---|---| |UNH|UNH.N|UnitedHealth Group|20240730|34.531966|1.3351192047227298|6.11901912923069|169| |UNH|UNH.N|UnitedHealth Group|20240731|34.52178|1.3347253847501397|6.117214202796235|169| |UNH|UNH.N|UnitedHealth Group|20240801|34.318661|1.326872151179078|6.0812218462503465|169| |UNH|UNH.N|UnitedHealth Group|20240802|35.340845|1.3663931437225334|6.262351522555026|169| |UNH|UNH.N|UnitedHealth Group|20240805|34.150294|1.3203625386909705|6.0513874740102445|169| |UNH|UNH.N|UnitedHealth Group|20240806|34.053828|1.3166328318917349|6.034293758954527|169| |UNH|UNH.N|UnitedHealth Group|20240807|33.917816|1.3113741769636196|6.010192682447398|169| |UNH|UNH.N|UnitedHealth Group|20240808|33.927403|1.3117448310554691|6.011891436738649|169| |UNH|UNH.N|UnitedHealth Group|20240809|33.479224|1.2944167522615038|5.774114812095032|169| |UNH|UNH.N|UnitedHealth Group|20240812|33.870482|1.3095440723851126|5.841594534557235|169| 2. **P/S Ratio**: With a P/S ratio of 0.56, UNH's valuation based on sales is also above the industry average. This indicates that the market may be expecting high growth rates in the future to justify the current valuation. 3. **Price to Book Ratio**: The company's Price to Book Ratio is 2.36, which is higher than the industry average. This suggests that the market is valuing the company's assets at a premium compared to its liabilities. Overall, while these metrics suggest that UNH may be overvalued, it's important to consider the company's strong market position, growth prospects, and the industry's high demand for its services. Analysts remain bullish on UNH, with a average current price target of $357.96, indicating a potential for the stock to regain some of its lost ground.